Showing results 1 to 2 of 2
Title | Author(s) | Issue Date | |
---|---|---|---|
CCR5 antagonist TD-0680 uses a novel mechanism for enhanced potency against HIV-1 entry, cell-mediated infection, and a resistant variant Journal:Journal of Biological Chemistry | 2012 | ||
2012 |